Skip Navigation


NDT Advance Access originally published online on August 17, 2004
Nephrology Dialysis Transplantation 2004 19(11):2754-2760; doi:10.1093/ndt/gfh454
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/11/2754    most recent
gfh454v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Branten, A. J. W.
Right arrow Articles by Wetzels, J. F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Branten, A. J. W.
Right arrow Articles by Wetzels, J. F. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant Vol. 19 No. 11 © ERA-EDTA 2004; all rights reserved


Original Article

Serum ferritin levels are increased in patients with glomerular diseases and proteinuria

Amanda J. W. Branten1, Dorine W. Swinkels2, Ina S. Klasen2 and Jack F. M. Wetzels1

1 Department of Medicine, Division of Nephrology and 2 Department of Clinical Chemistry, University Medical Center, Nijmegen, The Netherlands

Correspondence and offprint requests to: A. J. W. Branten, MD, Department of Medicine, Division of Nephrology 545, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Email: A.Branten{at}nier.umcn.nl

Background. Ferritin is a high molecular weight protein which reflects body iron stores, but may also rise in the case of an acute phase response. Recently, ferritin has been identified as a predictive factor in the development and progression of atherosclerosis. This is the first report on serum ferritin levels in patients with proteinuria.

Methods. We have analysed the data of 142 male patients with a glomerular disease, and proteinuria exceeding 1 g/day. In all patients, we measured various parameters related to proteinuria, serum ferritin and serum iron. Serum ß2-microglobulin and the Modification of Diet in Renal Disease (MDRD) equation were used as measures of the glomerular filtration rate (GFR).

Results. Mean age (±SD) was 46±15 years, MDRD-GFR 57±25 ml/min/1.73 m2 and median proteinuria 8.0 g/day [interquartile range (IQR) 3.6–13]. Serum albumin (29±9 g/l) and transferrin levels (1.7±0.5 g/l) were low, and cholesterol levels were elevated (median 7.3, IQR 5.9–9.5 mmol/l). Median serum ferritin was 148 µg/l (IQR 89–282), and exceeded 280 µg/l, the upper limit of normal, in 36 patients (25%). Elevated serum ferritin levels could not be explained by an acute phase response as determined by C-reactive protein, or haemochromatosis (DNA analysis). Regression analysis showed an independent relationship between ferritin levels and serum cholesterol, GFR and serum transferrin.

Conclusions. Serum ferritin levels are elevated in patients with overt proteinuria. The independent negative relationship between serum ferritin and transferrin points to a specific process and suggests that increased production of ferritin may compensate for the loss of the iron-binding protein transferrin, thus reducing the amount of free iron. Further studies are needed to elucidate the role of ferritin in patients with proteinuria, especially because of the suggested association between ferritin and atherosclerosis.

Keywords: ferritin; glomerulopathy; iron; proteinuria


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
K. Kalantar-Zadeh, K. Kalantar-Zadeh, and G. H. Lee
The Fascinating but Deceptive Ferritin: To Measure It or Not to Measure It in Chronic Kidney Disease?
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(Supplement_1): S9 - S18.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.